Your browser doesn't support javascript.
loading
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.
Montero-Conde, Cristina; Graña-Castro, Osvaldo; Martín-Serrano, Guillermo; Martínez-Montes, Ángel M; Zarzuela, Eduardo; Muñoz, Javier; Torres-Perez, Rafael; Pita, Guillermo; Cordero-Barreal, Alfonso; Leandro-García, Luis J; Letón, Rocío; López de Silanes, Isabel; Guadalix, Sonsoles; Pérez-Barrios, Andrés; Hawkins, Federico; Guerrero-Álvarez, Almudena; Álvarez-Escolá, Cristina; Regojo-Zapata, Rita M; Calsina, Bruna; Remacha, Laura; Roldán-Romero, Juan M; Santos, María; Lanillos, Javier; Jordá, Mireia; Riesco-Eizaguirre, Garcilaso; Zafon, Carles; González-Neira, Anna; Blasco, Maria A; Al-Shahrour, Fátima; Rodríguez-Antona, Cristina; Cascón, Alberto; Robledo, Mercedes.
Afiliação
  • Montero-Conde C; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Graña-Castro O; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Martín-Serrano G; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Martínez-Montes ÁM; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Zarzuela E; Proteomics Core Unit and Proteored-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Muñoz J; Proteomics Core Unit and Proteored-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Torres-Perez R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Pita G; CEGEN Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Cordero-Barreal A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Leandro-García LJ; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Letón R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • López de Silanes I; Telomeres and Telomerase Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Guadalix S; Endocrinology and Nutrition Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Pérez-Barrios A; Anatomical Pathology Section, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Hawkins F; Endocrinology and Nutrition Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Guerrero-Álvarez A; Endocrinology and Nutrition Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Álvarez-Escolá C; Endocrinology and Nutrition Department, Madrid, Spain.
  • Regojo-Zapata RM; Anatomical Pathology Section Hospital Universitario La Paz, Madrid, Spain.
  • Calsina B; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Remacha L; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Roldán-Romero JM; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Santos M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Lanillos J; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Jordá M; Program for Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute, Barcelona, Spain.
  • Riesco-Eizaguirre G; Endocrinology and Nutrition Department, Hospital Universitario de Móstoles, Madrid, Spain.
  • Zafon C; Biomedical Research Networking Centre in Oncology (CIBERONC), Institute of Health Carlos III, Madrid, Spain.
  • González-Neira A; Universidad Francisco de Vitoria, Madrid, Spain.
  • Blasco MA; Diabetes and Metabolism Research Unit and Endocrinology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Al-Shahrour F; Biomedical Research Networking Centre on Diabetes and Associated Metabolic Diseases (CIBERDEM), Institute of Health Carlos III, Madrid, Spain.
  • Rodríguez-Antona C; CEGEN Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Cascón A; Telomeres and Telomerase Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Robledo M; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Int J Cancer ; 146(2): 521-530, 2020 01 15.
Article em En | MEDLINE | ID: mdl-31403184
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Ribonucleoproteínas Nucleares Heterogêneas Grupo F-H / MicroRNAs Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Ribonucleoproteínas Nucleares Heterogêneas Grupo F-H / MicroRNAs Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha